Tech Company Financing Transactions
CytoVale Funding Round
CytoVale, based in San Francisco, received $7.2 million from private investors.
Transaction Overview
Company Name
Announced On
12/28/2017
Transaction Type
Venture Equity
Amount
$7,249,989
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 7 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
150 Executive Park Blvd. 4100
San Francisco, CA 94134
USA
San Francisco, CA 94134
USA
Phone
Undisclosed
Website
Email Address
Overview
We're inspired by the power of biology and driven to build tools that make it possible to access that power in new ways.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ajay Shah
Chief Operating Officer
Jennifer Beedon
VP - Engineering
Henry Tse
Browse more venture capital transactions:
Prev: 12/28/2017: NexImmune venture capital transaction
Next: 12/28/2017: Katerra venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs